Abstract
Age-related outcomes in MSI/dMMR gastrointestinal cancers treated by immune checkpoint inhibitors and toxicity’s impact on efficacy: an immunoMSI cohort study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have